References

1. Couch, V.M.S.; Lindor, N.M.; Karnes, P.S.; Michels, V.V. Von Hippel-Lindau disease. Mayo Clin. Proc. 2000, 75, 265-272.

2. Latif, F.; Tory, K.; Gnarra, J.; Yao, M.; Duh, F.-M.; Orcutt, M.L.; Stackhouse, T.; Kuzmin, I.; Modi, W.; Geil, L.; Schmidt, L.; Zhou, F.; Li, H.; Wei, M.H.; Chen, F.; Glenn, G.; Choyke, P.; Walther, M.M.; Weng, Y.; Duan, D.-S.R.; Dean, M.; Glavac, D.; Richards, F.M.; Crossey, P.A.; Ferguson-Smith, M.A.; Le Paslier, D.; Chumakov, I.; Cohen, D.; Chinault, C.; Maher, E.R.; Linehan, W.M.; Zbar, B.; Lerman, M.I. Identification of the von Hippel-Lindau disease tumour suppressor gene. Science 1993, 260, 1317-1320.

3. Crossey, P.A.; Foster, K.; Richards, F.M.; Phipps, M.E.; Latif, F.; Tory, K.; Jones, M.H.; Bentley, E.; Kumar, R.; Lerman, M.I. Molecular genetic investigations of the mechanism of tumourigenesis in von Hippel-Lindau disease: Analysis of allele loss in VHL tumours. Hum. Genet. 1994, 93, 53-58.

4. Singh, A.D.; Shields, C.L.; Shields, J.A. Von Hippel-Lindau disease. Surv. Opthalmol. 2001, 46, 117-142.

5. Zbar, B.; Kishida, T.; Chen, F.; Schmidt, L.; Maher, E.R.; Richards, F.M.; Crossey, P.A.; Webster, A.R.; Affara, N.A.; Ferguson-Smith, M.A.; Brauch, H.; Glavac, D.; Neumann, H.P.H.; Tisherman, S.; Mulvihill, J.J.; Gross, D.J.; Shuin, T.; Whaley, J.; Seizinger, B.; Kley, N.; Olschwang, S.; Boisson, C.; Richard, S.; Lips, C.H.M.; Linehan, W.M.; Lerman, M. Germline mutations in the von-Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan. Hum. Mutat. 1996, 8, 348-357.

6. Schimke, R.N.; Collins, D.L.; Stolle, C.A. Von Hippel-Lindau syndrome. Gene Rev. 2002. Available at: http:// www.genetests.org/profiles/vhl/index.html. [Last accessed: January 27, 2004].

7. Lonser, R.R.; Glenn, G.M.; Walther, M.; Chew, E.Y.; Libutti, S.K.; Linehan, W.M.; Oldfield, E.H. Von Hippel-Lindau disease. Lancet 2003, 361, 2059-2067.

8. Iliopoulos, O.; Levy, A.P.; Jiang, C.; Kaelin, W.G.; Goldberg, M.A. Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc. Natl. Acad. Sci. U. S. A. 1996, 93, 10595-10599.

9. Bryant, J.; Farmer, J.; Kessler, L.J.; Townsend, R.R.; Nathanson, K.L. Pheochromocytoma: The expanding genetic differential diagnosis. JNCI 2003, 95, 1196-1204.

10. Maxwell, P.H.; Wiesener, M.S.; Chang, G.-W.; Clifford, S.C.; Vaux, E.C.; Cockman, M.E.; Wykoff, C.C.; Pugh, C.W.; Maher, E.R.; Ratcliffe, P.J. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999, 399, 271-275.

11. George, D.J.; Kaelin, W.G. The von Hippel-Lindau protein, vascular endothelial growth factor, and kidney cancer. New Engl. J. Med. 2003, 349, 419-421.

12. Stolle, C.; Glenn, G.; Zbar, B.; Humphrey, J.S.; Choyke, P.; Walther, M.; Pack, S.; Hurley, K.; Andrey, C.; Klausner, R.; Linehan, W.M. Improved detection of

Getting Started With Dumbbells

Getting Started With Dumbbells

The use of dumbbells gives you a much more comprehensive strengthening effect because the workout engages your stabilizer muscles, in addition to the muscle you may be pin-pointing. Without all of the belts and artificial stabilizers of a machine, you also engage your core muscles, which are your body's natural stabilizers.

Get My Free Ebook


Post a comment